No evidence of increased ocular involvement in candidemic patients initially treated with echinocandins

Diagn Microbiol Infect Dis. 2017 Jun;88(2):141-144. doi: 10.1016/j.diagmicrobio.2017.02.014. Epub 2017 Feb 27.

Abstract

Candins are commonly used as initial therapy in patients with candidemia and are known to diffuse poorly into ocular tissue. The aim of our multicenter study was to assess whether eye involvement was more common in patients initially treated with echinocandins. We performed a post hoc analysis of a prospective, multicenter, population-based candidemic surveillance program implemented in Spain during 2010-2011 (CANDIPOP project). Eye involvement was detected in 13 of 168 patients with candidemia (7.7%) who underwent ophthalmoscopy. Two patients had endophthalmitis, while the remaining patients had chorioretinitis. The frequency of ocular candidiasis was similar in patients receiving initial therapy with candins (3/56; 5.4%) or with other regimens (10/112; 8.9%). At multivariate analysis, risk conditions for eye involvement were dialysis after candidemia (OR, 19.4; 95% CI, 1.7-218.4) and involvement of organs other than the eye (OR, 5.4; 95% CI, 1.1-25.7). In conclusion, eye involvement was not found to be more frequent in patients receiving initial therapy with echinocandins than in patients receiving other drugs.

Keywords: Candida endophthalmitis; Echinocandins; Initial antifungal therapy.

Publication types

  • Multicenter Study

MeSH terms

  • Antifungal Agents / therapeutic use*
  • Candidemia / drug therapy*
  • Chorioretinitis / microbiology
  • Echinocandins / therapeutic use*
  • Endophthalmitis / microbiology
  • Eye Infections, Fungal / diagnosis
  • Eye Infections, Fungal / etiology*
  • Eye Infections, Fungal / microbiology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Spain

Substances

  • Antifungal Agents
  • Echinocandins